| Style | Citing Format |
|---|---|
| MLA | Azarpeikan A, et al.. "Application of Breast Scintigraphy for Patients With Suspicious (Breast Imaging-Reporting and Data System Iv) Breast Lesions." Advanced Biomedical Research, vol. 12, no. 1, 2023, pp. -. |
| APA | Azarpeikan A, Omranipour R, Mahmoodzadeh H, Miri S, Mohammadzadeh N, Derakhshan F, Farzanehfar S, Abbasi M (2023). Application of Breast Scintigraphy for Patients With Suspicious (Breast Imaging-Reporting and Data System Iv) Breast Lesions. Advanced Biomedical Research, 12(1), -. |
| Chicago | Azarpeikan A, Omranipour R, Mahmoodzadeh H, Miri S, Mohammadzadeh N, Derakhshan F, Farzanehfar S, Abbasi M. "Application of Breast Scintigraphy for Patients With Suspicious (Breast Imaging-Reporting and Data System Iv) Breast Lesions." Advanced Biomedical Research 12, no. 1 (2023): -. |
| Harvard | Azarpeikan A et al. (2023) 'Application of Breast Scintigraphy for Patients With Suspicious (Breast Imaging-Reporting and Data System Iv) Breast Lesions', Advanced Biomedical Research, 12(1), pp. -. |
| Vancouver | Azarpeikan A, Omranipour R, Mahmoodzadeh H, Miri S, Mohammadzadeh N, Derakhshan F, et al.. Application of Breast Scintigraphy for Patients With Suspicious (Breast Imaging-Reporting and Data System Iv) Breast Lesions. Advanced Biomedical Research. 2023;12(1):-. |
| BibTex | @article{ author = {Azarpeikan A and Omranipour R and Mahmoodzadeh H and Miri S and Mohammadzadeh N and Derakhshan F and Farzanehfar S and Abbasi M}, title = {Application of Breast Scintigraphy for Patients With Suspicious (Breast Imaging-Reporting and Data System Iv) Breast Lesions}, journal = {Advanced Biomedical Research}, volume = {12}, number = {1}, pages = {-}, year = {2023} } |
| RIS | TY - JOUR AU - Azarpeikan A AU - Omranipour R AU - Mahmoodzadeh H AU - Miri S AU - Mohammadzadeh N AU - Derakhshan F AU - Farzanehfar S AU - Abbasi M TI - Application of Breast Scintigraphy for Patients With Suspicious (Breast Imaging-Reporting and Data System Iv) Breast Lesions JO - Advanced Biomedical Research VL - 12 IS - 1 SP - EP - PY - 2023 ER - |